Céline Nicolazzi
Inventor
Stats
- 1 US patents issued
- 9 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 1 US Patents Issued
- 9 US Applications Filed
- 3 Total Citation Count
- Aug 27, 2024 Most Recent Filing
- Jan 11, 2012 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| AVENTIS PHARMA S.A. | 1
1 | 2012
2013 |
Inventor Addresses
| Address | Duration |
|---|---|
| Paris, FR | Jul 09, 13 - Dec 26, 24 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 7 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 7 |
| C07K: | PEPTIDES | 6 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2024/0424,126 | 2024 | CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | 0 |
| 2024/0226,313 | 2024 | CEACAM5 ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF | 1 |
| 2023/0181,755 | 2023 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES, TRIFLURIDINE AND TIPIRACIL | 1 |
| 2023/0151,088 | 2023 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND FOLFOX | 1 |
| 2023/0149,557 | 2023 | ANTITUMOR COMBINATIONS CONTAINING ANTI-CEACAM5 ANTIBODY CONJUGATES AND CETUXIMAB | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.